Dean Li

Track

Insider profile

Currently holds a position at Recursion Pharmaceuticals Inc

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Co-Founder, Chief Scientific Officer Recursion Pharmaceuticals Inc None -
Dean Li's trades of Merck & Co Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
194.61
Quantity 77,189
Value US$2,507,027
Transaction date
Sale
Price
30.57
Quantity 47,202 -32.3%
Value US$626,970
Transaction date
Sale
Price
206.84
Quantity 39,127 +33.7%
Value US$313,838
Transaction date
Proposed sale
Price
118.77
Quantity 15,087
Value US$1,791,824
Transaction date
Sale
Price
125.50
Quantity 14,702 -24.1%
Value US$1,845,083
Transaction date
Proposed sale
Price
125.50
Quantity 14,702
Value US$1,845,083
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-10 2026-02-10
PrS Proposed sale
77,189
194.61
US$2,507,027 		77,189 194.61 US$2,507,027
2026-02-10 2026-02-10
S Sale
47,202 -32.3%
30.57
US$626,970 		47,202 -32.3% 30.57 US$626,970
2026-02-06 2026-02-04
S Sale
39,127 +33.7%
206.84
US$313,838 		39,127 +33.7% 206.84 US$313,838
2026-02-04 2026-02-04
PrS Proposed sale
15,087
118.77
US$1,791,824 		15,087 118.77 US$1,791,824
2024-02-12 2024-02-09
S Sale
14,702 -24.1%
125.50
US$1,845,083 		14,702 -24.1% 125.50 US$1,845,083
2024-02-09 2024-02-09
PrS Proposed sale
14,702
125.50
US$1,845,083 		14,702 125.50 US$1,845,083
2024-01-11 2024-01-09
PlS Planned sale
962 -0.2%
14.03
US$13,495 		962 -0.2% 14.03 US$13,495
2024-01-11 2024-01-09
PlS Planned sale
28,038 -6.2%
13.65
US$382,719 		28,038 -6.2% 13.65 US$382,719
2024-01-09 2024-01-09
PrS Proposed sale
29,000
13.66
US$396,193 		29,000 13.66 US$396,193
2024-01-09 2024-01-09
PrS Proposed sale
29,000
13.68
US$396,822 		29,000 13.68 US$396,822
2021-12-09 2021-12-07
PlS Planned sale
1,000 -0.1%
21.06
US$21,058 		1,000 -0.1% 21.06 US$21,058
2021-12-09 2021-12-07
PlS Planned sale
14,900 -1.1%
20.44
US$304,572 		14,900 -1.1% 20.44 US$304,572
2021-11-19 2021-11-19
PlS Planned sale
13,474 -2.3%
20.20
US$272,226 		13,474 -2.3% 20.20 US$272,226
2021-11-19 2021-11-17
PlS Planned sale
5,626 -0.9%
20.04
US$112,736 		5,626 -0.9% 20.04 US$112,736